Altered Urinary Metabolomics in Hereditary Angioedema

Area of Science:

• Biochemistry
• Metabolomics
• Genetics

Background:

• Hereditary angioedema (HAE) is a rare, severe condition with varied symptoms.
• The metabolic profile of HAE is not well understood.
• Identifying metabolic signatures could reveal HAE pathogenesis and biomarkers.

Purpose of the Study:

• To characterize the metabolomic profile of HAE patients.
• To identify potential metabolic biomarkers for HAE.
• To explore metabolic differences based on HAE mutation types.

Main Methods:

• Urine samples from 34 HAE patients and 82 healthy controls were analyzed.
• High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was employed.
• Statistical analysis identified significant differential metabolites (VIP > 1.0, q < 0.05, FC ≥ 1.2 or ≤ 0.8).

Main Results:

• 795 metabolites were quantified; 73 were identified as differential in HAE patients.
• Altered metabolites included those in riboflavin metabolism (e.g., vitamin B2), purine metabolism (e.g., xanthine), the citrate cycle (e.g., isocitrate), and oxidative stress markers.
• No significant metabolic differences were observed between HAE patients with different mutation types.

Conclusions:

• Metabolic alterations in purine metabolism, riboflavin metabolism, and the TCA cycle are implicated in HAE pathogenesis.
• The identified metabolites represent potential novel biomarkers for HAE.
• Further research is needed to confirm the biochemical significance of these findings.